For instance, in patients with SCN1A mutations and Dravet syndrome, sodium channel-blocking AEDs like stiripentol have shown better efficacy [27]. Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.